Evidence map›Paper›PMID 37171075›Full record

ArticleeLife2023

APOE expression and secretion are modulated by mitochondrial dysfunction.

Meghan E Wynne, Oluwaseun Ogunbona, Alicia R Lane, Avanti Gokhale, Stephanie A Zlatic, Chongchong Xu, Zhexing Wen, Duc M Duong, Sruti Rayaprolu, Anna Ivanova and 17 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Genetic and environmental risk factors for dementia in African adults: A systematic review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Inhibiting mtDNA transcript translation alters Alzheimer's disease-associated biology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 5 institutions in 1 country.

Meghan E WynneDepartment of Cell Biology, Emory University, Atlanta, United States.
Oluwaseun OgunbonaDepartment of Cell Biology, Emory University, Atlanta, United States.
Alicia R LaneDepartment of Cell Biology, Emory University, Atlanta, United States.ORCID 0000-0002-6404-7559
Avanti GokhaleDepartment of Cell Biology, Emory University, Atlanta, United States.
Stephanie A ZlaticDepartment of Cell Biology, Emory University, Atlanta, United States.
Chongchong XuDepartment of Psychiatry and Behavioral Sciences, Emory University, Atlanta, United States.
Zhexing WenDepartment of Cell Biology, Emory University, Atlanta, United States.
Duc M DuongDepartment of Biochemistry, Emory University, Atlanta, United States.
Sruti RayaproluDepartment of Neurology and Human Genetics, Emory University, Atlanta, United States.
Anna IvanovaDepartment of Biochemistry, Emory University, Atlanta, United States.ORCID 0000-0002-6221-6240
Eric A OrtlundDepartment of Biochemistry, Emory University, Atlanta, United States.
Eric B DammerDepartment of Biochemistry, Emory University, Atlanta, United States.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University, Atlanta, United States.
Blaine R RobertsDepartment of Biochemistry, Emory University, Atlanta, United States.
Amanda CrockerProgram in Neuroscience, Middlebury College, Middlebury, United States.
Vinit ShanbhagDepartment of Biochemistry, University of Missouri, Columbia, United States.
Michael PetrisDepartment of Biochemistry, University of Missouri, Columbia, United States.
Nanami SenooDepartment of Physiology, Johns Hopkins University, Baltimore, United States.
Selvaraju KandasamyDepartment of Physiology, Johns Hopkins University, Baltimore, United States.
Steven Michael ClaypoolDepartment of Physiology, Johns Hopkins University, Baltimore, United States.ORCID 0000-0001-5316-1623
Antoni BarrientosDepartment of Neurology and Biochemistry & Molecular Biology, University of Miami, Miami, United States.ORCID 0000-0001-9018-3231
Aliza WingoDepartment of Neurology and Human Genetics, Emory University, Atlanta, United States.
Thomas S WingoDepartment of Neurology and Human Genetics, Emory University, Atlanta, United States.ORCID 0000-0002-7679-6282
Srikant RangarajuDepartment of Neurology and Human Genetics, Emory University, Atlanta, United States.
Allan I LeveyDepartment of Neurology and Human Genetics, Emory University, Atlanta, United States.ORCID 0000-0002-3153-502X
Erica WernerDepartment of Cell Biology, Emory University, Atlanta, United States.ORCID 0000-0002-8183-1601
Victor FaundezDepartment of Cell Biology, Emory University, Atlanta, United States.ORCID 0000-0002-2114-5271
Emory University · USJohns Hopkins University · USUniversity of Missouri · USMiddlebury College · USUniversity of Miami · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
The Goizueta Alzheimer's Disease Research CenterP30AG066511 · NIA · EMORY UNIVERSITY · PI Nicholas Thomas Seyfried · 2020 to 2026
$29.0M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
Supplement to AMP-AD Brain Proteomic Network Enhancement, Validation and Translation into CSF BiomarkersU01AG061357 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I, SEYFRIED, NICHOLAS THOMAS · 2018 to 2022
$9.1M
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer’s diseaseR01AG075820 · NIA · YALE UNIVERSITY · PI RANGARAJU, SRIKANT, SEYFRIED, NICHOLAS THOMAS · 2021 to 2025
$5.1M
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGYT32NS007480 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2000 to 2020
$4.5M
Training In Systems And Integrative Biology NeuroscienceT32NS096050 · NINDS · EMORY UNIVERSITY · PI Yoland Smith · 2016 to 2026
$3.9M
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's DiseaseR01NS114130 · NINDS · YALE UNIVERSITY · PI RANGARAJU, SRIKANT · 2020 to 2024
$3.1M
Neuronal Mechanisms of Copper Transport and ToxicityRF1AG060285 · NIA · EMORY UNIVERSITY · PI FAUNDEZ, VICTOR · 2018 to 2021
$2.4M
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimer’s diseaseRF1AG071587 · NIA · YALE UNIVERSITY · PI RANGARAJU, SRIKANT · 2021 to 2021
$2.1M
Defining microglial and endothelial cell-type specific proteomic alterations of APOE risk in Alzheimer's diseaseF32AG064862 · NIA · EMORY UNIVERSITY · PI RAYAPROLU, SRUTI · 2019 to 2021
$195k
Metabolic Mechanisms of Copper-Dependent Neurodegeneration and Excitability in Menkes DiseaseF31NS127419 · NINDS · EMORY UNIVERSITY · PI LANE, ALICIA R · 2022 to 2024
$143k
NCATS NIH HHS UL1 TR002378NIA NIH HHS F31 AG067623NIA NIH HHS F32 AG064862NIA NIH HHS P30 AG066511NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG075820NIA NIH HHS RF1 AG060285NIA NIH HHS RF1 AG071587NIA NIH HHS U01 AG061357NINDS NIH HHS F31 NS127419NINDS NIH HHS R01 NS114130NINDS NIH HHS T32 NS007480NINDS NIH HHS T32 NS096050
6 · The paper itself

Abstract

Mitochondria influence cellular function through both cell-autonomous and non-cell autonomous mechanisms, such as production of paracrine and endocrine factors. Here, we demonstrate that mitochondrial regulation of the secretome is more extensive than previously appreciated, as both genetic and pharmacological disruption of the electron transport chain caused upregulation of the Alzheimer's disease risk factor apolipoprotein E (APOE) and other secretome components. Indirect disruption of the electron transport chain by gene editing of SLC25A mitochondrial membrane transporters as well as direct genetic and pharmacological disruption of either complexes I, III, or the copper-containing complex IV of the electron transport chain elicited upregulation of APOE transcript, protein, and secretion, up to 49-fold. These APOE phenotypes were robustly expressed in diverse cell types and iPSC-derived human astrocytes as part of an inflammatory gene expression program. Moreover, age- and genotype-dependent decline in brain levels of respiratory complex I preceded an increase in APOE in the 5xFAD mouse model. We propose that mitochondria act as novel upstream regulators of APOE-dependent cellular processes in health and disease.

Indexed as

Apolipoprotein E4MitochondriaAnimalsApolipoproteins EAstrocytesGenotypeHumansMiceApolipoprotein E4Apolipoproteins Ealzheimer's diseaseAPOEcell biologyhumanmitochondrianeuroscience

Identifiers

PMID37171075
PMCPMC10231934
OpenAlexW4376223985

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.